BRYAN KLOPP: Open Payments
NPI 1982291464 · BROWNSTOWN TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 36 payments from 14 companies in 2025. Trend: 2023 $43 · 2024 $816 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $176 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| Genentech USA, Inc. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Incyte Corporation | 3 | $65 |
| SOBI, INC | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $48 |
| Eisai Inc. | 2 | $43 |
| BeOne Medicines USA, Inc. | 2 | $42 |
Products named: KISQALI, KEYTRUDA, Enhertu, Doptelet, Polivy, Lenvima, Trodelvy, FRUZAQLA.
Industry payments across MI — which companies pay providers there.
